OpenVSafe by OpenVAERS
Search V-safe

WC3-10593-44251

2 vaccinations 1 coded response 1 check-in 1 free-text entry 0 call cases
Sex
Female
Age at first dose
05-11
ZIP prefix
913 / CA
Registered
2022-04-19
Relationship
Child or adolescent in my care
Guardian
9NB-10085-86498
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-12-05
    Dose 1 — Pfizer-BioNTech
  2. 2021-12-26
    Dose 2 — Pfizer-BioNTech
  3. 2022-04-19
    Registered in v-safe
  4. 2022-06-26
    Survey response — 6 months, dose 2, dependent
    MedDRA: Exposure to SARS-CoV-2, Nasopharyngitis, SARS-CoV-2 test negative, Sinusitis — Feeling: Good · Be unable to work or attend school
    Free text: She had a cold/sinus infection at some point over the last few months. She was still in school. She received a letter saying she had been in close contact with a classmate who tested positive for COVID-19. I tested (b)(6) 3 times and she was negative.
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-12-05Pfizer-BioNTech No
22021-12-26Pfizer-BioNTech No

Free text

Release 12 — 6 months, dose 2, dependent

2022-06-26

Symptoms: She had a cold/sinus infection at some point over the last few months. She was still in school. She received a letter saying she had been in close contact with a classmate who tested positive for COVID-19. I tested (b)(6) 3 times and she was negative. cut off by CDC
redacted (b)(6)

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDExposure to SARS-CoV-2 · · ✓
SDNasopharyngitis · · ✓
SDSARS-CoV-2 test negative · · ✓
SDSinusitis · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release